Relcer, 180 ml suspension

Pharmacodynamics

It neutralizes free hydrochloric acid in the stomach, which leads to a decrease in the digestive activity of gastric juice. Does not cause secondary hypersecretion of gastric juice.

It has an adsorptive and enveloping effect, reduces the effect of damaging factors on the gastric mucosa. It accelerates healing of gastric and duodenal ulcers.

Limits gas in the intestines.

Indications

peptic ulcer of the stomach and duodenum in the acute phase;
acute gastritis, chronic gastritis with increased and normal secretory function in the acute phase; duodenitis;
hiatal hernia; reflux esophagitis;
discomfort and pain in the epigastrium due to errors in diet, after taking medications, drinking coffee, nicotine, alcohol.

Pharmacological effect

Pharmacodynamics

Neutralizes free hydrochloric acid in the stomach, which leads to a decrease in the digestive activity of gastric juice. Does not cause secondary hypersecretion of gastric juice.

It has an adsorbing and enveloping effect, reduces the effect of damaging factors on the gastric mucosa. Accelerates the healing of stomach and duodenal ulcers.

Reduces gas formation in the intestines.

Special instructions

The interval between taking Relzer and other drugs should be 1-2 hours.

Long-term use (more than 14 days) requires regular medical supervision.

The drug contains sorbitol, which is contraindicated in cases of congenital fructose intolerance.

Composition

5 ml of suspension contains:

Active substances:

– aluminum hydroxide gel 6 g;

– magnesium hydroxide 80 mg;

– simethicone 100 mg;

– licorice root powder 400 mg.

Excipients:

guar gum;

sorbitol;

sodium benzoate;

sodium citrate;

methylparaben;

propylparaben;

sodium saccharinate;

sodium hypochlorite;

sodium hydroxide;

peppermint oil;

banana fragrance;

bronopol;

purified water.

Pregnancy

Contraindicated during pregnancy.

Breastfeeding should be stopped during treatment.

Contraindications

hypersensitivity to the components of the drug;
fructose intolerance;
hypophosphatemia;
severe renal dysfunction;
Alzheimer’s disease;
pregnancy;
breastfeeding period;
children under 10 years of age.

Side Effects

Constipation, nausea, vomiting, stomach cramps, changes in taste, hypermagnesemia, hypophosphatemia, hypocalcemia, hypercalciuria, osteomalacia, osteoporosis, hyperaluminemia, encephalopathy, nephrocalcinosis, renal dysfunction, allergic reactions.

In patients with concomitant renal failure – thirst, decreased blood pressure, hyporeflexia.

Interaction

May adsorb some drugs, thus reducing their absorption.

Reduces and slows down the absorption of digoxin, indomethacin, salicylates, chlorpromazine, phenytoin, H2-histamine blockers, beta-blockers, diflunisal, isoniazid, tetracycline antibiotics, quinolones (ciprofloxacin, norfloxacin, ofloxacin, enoxacin, grepafloxacin, etc.), azithromycin, cefpodoxime, pivampicillin, rifampicin, indirect anticoagulants, barbiturates, fexofenadine, dipyridamole, zalcitabine, bile acids – chenodeoxycholic and ursodeoxycholic, penicillamine, iron and lithium preparations, quinidine, lansoprazole, mexiletine, ketoconazole.

When taken simultaneously with drugs in enteric dosage forms, increased alkalinity of gastric juice can lead to accelerated breakdown of the membrane and irritation of the stomach and duodenum.

m-Anticholinergic blockers, by slowing down gastric emptying, enhance and prolong the effect of the drug.

Overdose

Symptoms: with prolonged use of high doses, the formation of kidney stones, constipation, drowsiness, and hypermagnesemia are possible.

Signs of metabolic alkalosis may also be observed: mood changes, numbness or muscle pain, nervousness and fatigue, and unpleasant taste sensations.

Treatment: it is necessary to take measures to quickly eliminate the drug: rinse the stomach, induce vomiting, take activated charcoal.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 25 °C.

Shelf life

4 years.

Manufacturer

Glenmark Pharmaceuticals Ltd, India